tldrdailynews.com logo

Amgen's Repatha reduces first-time heart attack and stroke risk by 25%

1 min read
Source: statnews.com
Amgen's Repatha reduces first-time heart attack and stroke risk by 25%
Photo: statnews.com
TL;DR

A study published in the New England Journal of Medicine shows that Amgen's cholesterol injection Repatha significantly reduces the risk of heart attacks, strokes, and cardiovascular death in high-risk individuals without prior events, outperforming traditional statin therapy.

Topics:businesshealth#amgen#cholesterol#health#heart-attack#repatha#stroke
Share this article
  1. Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm  statnews.com
  2. Amgen cholesterol drug cuts risk of first cardiac event by 25%  Reuters
  3. Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV  TCTMD.com
  4. PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke  www.heart.org
  5. AHA25: Amgen's Repatha clears 25% mark in preventing first cardiac events  FirstWord Pharma

Want the full story? Read the original reporting

Read on statnews.com